IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.817
EU - Europa 27.776
AS - Asia 18.109
SA - Sud America 4.611
AF - Africa 394
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 109
Totale 94.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.434
SG - Singapore 7.524
GB - Regno Unito 7.039
RU - Federazione Russa 6.661
CN - Cina 4.684
IT - Italia 4.376
BR - Brasile 3.793
VN - Vietnam 2.304
UA - Ucraina 2.299
DE - Germania 2.194
CA - Canada 1.953
DK - Danimarca 1.526
HK - Hong Kong 1.387
SE - Svezia 797
FR - Francia 532
IE - Irlanda 530
FI - Finlandia 512
PL - Polonia 488
IN - India 348
AR - Argentina 325
MX - Messico 321
IL - Israele 265
NL - Olanda 260
BD - Bangladesh 253
TR - Turchia 236
ID - Indonesia 182
EC - Ecuador 170
JP - Giappone 162
ZA - Sudafrica 158
ES - Italia 145
PK - Pakistan 135
IQ - Iraq 128
EU - Europa 106
AT - Austria 104
AU - Australia 78
CO - Colombia 76
IR - Iran 65
KR - Corea 64
VE - Venezuela 58
UZ - Uzbekistan 57
SA - Arabia Saudita 54
MA - Marocco 51
PY - Paraguay 50
AE - Emirati Arabi Uniti 47
LT - Lituania 47
CL - Cile 45
PE - Perù 42
KE - Kenya 38
RO - Romania 38
BE - Belgio 33
NZ - Nuova Zelanda 30
EG - Egitto 29
CH - Svizzera 27
UY - Uruguay 27
SK - Slovacchia (Repubblica Slovacca) 26
JO - Giordania 24
TN - Tunisia 24
CZ - Repubblica Ceca 22
AZ - Azerbaigian 20
DZ - Algeria 20
BO - Bolivia 19
ET - Etiopia 18
CR - Costa Rica 16
TW - Taiwan 16
MY - Malesia 15
NP - Nepal 15
DO - Repubblica Dominicana 14
JM - Giamaica 14
KZ - Kazakistan 14
HN - Honduras 13
PH - Filippine 13
AM - Armenia 11
KG - Kirghizistan 11
PT - Portogallo 11
TH - Thailandia 11
BY - Bielorussia 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
AL - Albania 9
BG - Bulgaria 9
GE - Georgia 9
GR - Grecia 9
QA - Qatar 9
LV - Lettonia 8
NO - Norvegia 8
OM - Oman 8
PS - Palestinian Territory 8
SN - Senegal 8
CI - Costa d'Avorio 7
GH - Ghana 7
GT - Guatemala 7
HU - Ungheria 7
KW - Kuwait 7
PA - Panama 7
BB - Barbados 6
EE - Estonia 6
MK - Macedonia 6
RS - Serbia 6
BH - Bahrain 5
BW - Botswana 5
Totale 94.825
Salva come PNG Salva come JPEG
Città #
Dallas 7.966
Southend 4.837
Singapore 4.004
Woodbridge 2.674
Beijing 2.330
Chandler 2.319
Ann Arbor 2.295
Houston 2.087
Ashburn 1.993
Fairfield 1.626
San Mateo 1.470
Falls Church 1.263
Hong Kong 1.187
Jacksonville 1.095
Seattle 1.078
Dearborn 1.020
Moscow 1.014
Cambridge 963
Wilmington 886
Ottawa 857
Los Angeles 837
Pisa 630
Chicago 599
Ho Chi Minh City 572
The Dalles 564
Hefei 540
Boardman 525
Stevenage 512
Dublin 506
Portsmouth 502
Dong Ket 483
Warsaw 455
New York 405
Montréal 403
São Paulo 386
Lawrence 385
Buffalo 316
Beauharnois 315
Brooklyn 300
Santa Clara 300
Hanoi 291
Munich 246
Tel Aviv 245
Rome 243
Milan 236
Salt Lake City 226
London 222
Redwood City 174
San Diego 168
Old Bridge 158
Florence 155
Montreal 135
Tokyo 133
Stockholm 132
Rio de Janeiro 131
Frankfurt am Main 130
Denver 122
Istanbul 122
Poplar 122
Chennai 117
Johannesburg 113
Orem 112
Fremont 110
Tampa 109
Atlanta 105
Phoenix 105
Elk Grove Village 104
Mexico City 103
Helsinki 100
Boston 99
Nuremberg 94
Toronto 85
San Francisco 71
Manchester 70
Amsterdam 69
Turku 69
Council Bluffs 68
Haiphong 68
Belo Horizonte 67
Brasília 67
Norwalk 67
Curitiba 64
Ankara 63
Livorno 61
Central District 60
Washington 60
Lappeenranta 58
Lucca 57
Porto Alegre 53
Tashkent 53
Guayaquil 51
Quito 51
Biên Hòa 50
Bologna 50
Da Nang 50
Campinas 49
Kansas City 49
Guangzhou 48
Querétaro 48
Shanghai 48
Totale 58.885
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.591
Value in Healthcare and the Role of the Patient Voice 1.048
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 656
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 546
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 444
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 439
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 424
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 407
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 401
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 349
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 338
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 327
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 325
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 314
Human pathophysiological adaptations to the space environment 312
La neuropatia diabetica 311
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 308
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 307
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 306
A simple echocardiographic score to rule out cardiac amyloidosis 301
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 290
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 290
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 290
Treating chemoreflex in heart failure: modulation or demolition? 289
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 287
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 286
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 284
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 283
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 282
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 281
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 279
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 278
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 276
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 275
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 274
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 273
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 271
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 271
Adrenergic activation in heart failure: blockade or rebalance? 270
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 269
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 267
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 265
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 265
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 265
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 263
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 261
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 258
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 258
Prediction of the chemoreflex gain by common clinical variables in heart failure 257
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 256
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 256
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 256
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 255
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 255
A simple echocardiographic score to rule out cardiac amyloidosis 252
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 252
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 250
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 250
[Central apneas and cardiovascular diseases] 248
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 248
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 248
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 247
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 247
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 245
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 244
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 243
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 243
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 242
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 242
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 242
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 241
Marcatori di rimodellamento e fibrosi cardiaca 241
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 240
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 239
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 239
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 235
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 233
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 233
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 232
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 231
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 231
Sex-related differences in chronic heart failure 231
How to take arms against central apneas in heart failure 230
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 230
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 229
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 229
Cardiac light-chain deposition disease relapsing in the transplanted heart 229
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 228
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 228
B-type natriuretic peptide secretion following scuba diving 227
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 227
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 226
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 226
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 225
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 225
Totale 29.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 506.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 506.657
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.328 0 0 0 0 0 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202628.754 2.676 8.082 5.678 6.166 5.331 821 0 0 0 0 0 0
Totale 95.564